REQUEST A DEMO
Total
USD $0.00
Search more companies

Medicannabis Polska Sp. z o.o. (Poland)

Main Activities: All Other Crop Farming
Secondary Activities: Oilseed and Grain Farming | Fats and Oils Refining and Blending | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | General Freight Trucking | Warehousing and Storage
Full name: Medicannabis Polska Sp. z o.o. Profile Updated: February 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Medicannabis Polska Sp. z o.o. is an enterprise based in Poland. Its main office is in Wolomin. The enterprise currently operates in the All Other Crop Farming sector. It was incorporated on February 09, 2023. A negative growth of 0.25% was recorded in its total assets.

Headquarters
Ul. Lukasiewicza 11
Wolomin; Mazowieckie; Postal Code: 05-200

Contact Details: Purchase the Medicannabis Polska Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Medicannabis Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Medicannabis Polska Sp. z o.o. report to view the information.
Incorporation Date:
February 09, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medicannabis Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit
-21.89%
Net Profit/Loss for the Period
-21.89%
Total Assets
-0.25%
Total Equity
-0.25%
Return on Equity (ROE)
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?